Relative quantification of human β‑defensins gene expression in pterygium and normal conjunctiva samples

Abubakar,Sa'adatu   Aliyu; Isa,Muhammad   Mohd; Omar,Nazri; Tan,Sheau   Wei

doi:10.3892/mmr.2020.11560

Relative quantification of human β‑defensins gene expression in pterygium and normal conjunctiva samples

Authors:
- Sa'adatu Aliyu Abubakar
- Muhammad Mohd Isa
- Nazri Omar
- Sheau Wei Tan
View Affiliations

Affiliations: Ophthalmology Unit, Department of Surgery, Faculty of Medicine and Health Science, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia, Institute of Bioscience, Universiti Putra Malaysia, Serdang, Selangor 43400, Malaysia
Published online on: October 5, 2020 https://doi.org/10.3892/mmr.2020.11560
Pages: 4931-4937

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The human ocular surface produces highly conserved cationic peptides. Human β‑defensins (HBDs) serve an important role in innate and adaptive immunity. They are primarily expressed in epithelial cells in response to infection and provide the first line of defence against invading microbes. Defensin β1 (DEFB1) is constitutively expressed and regulated by inflammatory mediators including interferon‑γ, lipopolysaccharide and peptidoglycans. DEFB4A is locally induced in response to microbial infection while DEFB109 is induced via Toll‑like receptor 2. The present study examined the expression of the HBD DEFB1, DEFB4A and DEFB109 genes in pterygium. The pterygium tissues and normal conjunctiva samples were obtained from 18 patients undergoing pterygium surgery. The reverse transcription‑quantitative polymerase chain reaction method was employed to determine the expression of DEFB1, DEFB4A and DEFB109 genes. The results revealed that the expression of DEFB1 and DEFB4A was significantly higher and upregulated in pterygium samples when compared with normal conjunctiva samples from each patient (P<0.05), while the expression of DEFB109 was observed to be lower in pterygium samples when compared with normal samples from the same patient. Previous studies have revealed that DEFB1 and DEFB4A genes are present in low concentrations inside the human eye, and they are upregulated during the maturation of keratinocytes, suggesting a possible role in cell differentiation. The DEFB109 gene is present in higher concentrations inside the human eye, though it is newly discovered. It has also been reported that DEFB1 may be involved in carcinogenesis epithelial tumours. Collectively, the current data suggests that HBDs may serve a crucial role in the pathogenesis and development of pterygia, and thus may be considered as novel molecular targets in understanding pterygia development.

View Figures

View References

1	Liu L, Zhao C, Heng HH and Ganz T: The human beta-defensin-1 and alpha-defensins are encoded by adjacent genes: Two peptide families with differing disulfide topology share a common ancestry. Genomics. 43:316–320. 1997. View Article : Google Scholar : PubMed/NCBI
2	Jia HP, Schutte BC, Schudy A, Linzmeier R, Guthmiller JM, Johnson GK, Tack BF, Mitros JP, Rosenthal A, Ganz T and McCray PB Jr: Discovery of new human beta-defensins using a genomics-based approach. Gene. 263:211–218. 2001. View Article : Google Scholar : PubMed/NCBI
3	Ganz T: Defensins: Antimicrobial peptides of innate immunity. Nat Rev Immunol. 3:710–720. 2003. View Article : Google Scholar : PubMed/NCBI
4	Zhou YS, Webb S, Lettice L, Tardif S, Kilanowski F, Tyrrell C, MacPherson H, Semple F, Tennant P, Baker T, et al: Partial deletion of chromosome 8 β-defensin cluster confers sperm dysfunction and infertility in male mice. PLoS Genet. 9:e10038262013. View Article : Google Scholar : PubMed/NCBI
5	Wilson SS, Wiens ME and Smith JG: Antiviral mechanisms of human defensins. J Mol Biol. 425:4965–4980. 2013. View Article : Google Scholar : PubMed/NCBI
6	Dhople V, Krukemeyer A and Ramamoorthy A: The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta. 1758:1499–1512. 2006. View Article : Google Scholar : PubMed/NCBI
7	Wehkamp J, Wang G, Kübler I, Nuding S, Gregorieff A, Schnabel A, Kays RJ, Fellermann K, Burk O, Schwab M, et al: The Paneth cell alpha-defensin deficiency of ileal Crohn's disease is linked to Wnt/Tcf-4. J Immunol. 179:3109–3118. 2007. View Article : Google Scholar : PubMed/NCBI
8	Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, Anderson M, Schröder JM, Wang JM, Howard OM and Oppenheim JJ: Beta-defensins: Linking innate and adaptive immunity through dendritic and T cell CCR6. Science. 286:525–528. 1999. View Article : Google Scholar : PubMed/NCBI
9	Al-Rayahi IA and Sanyi RH: The overlapping roles of antimicrobial peptides and complement in recruitment and activation of tumor-associated inflammatory cells. Front Immunol. 6:22015. View Article : Google Scholar : PubMed/NCBI
10	Masters JS and Harris DJ Jr: Low recurrence rate of pterygium after excision with conjunctival limbal Autograft: A retrospective study with long-term follow-up. Cornea. 34:1569–1572. 2015. View Article : Google Scholar : PubMed/NCBI
11	Lucas RM, McMichael AJ, Armstrong BK and Smith WT: Estimating the global disease burden due to ultraviolet radiation exposure. Int J Epidemiol. 37:654–667. 2008. View Article : Google Scholar : PubMed/NCBI
12	Nubile M, Curcio C, Lanzini M, Calienno R, Iezzi M, Mastropasqua A, Di Nicola M and Mastropasqua L: Expression of CREB in primary pterygium and correlation with cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. Ophthalmic Res. 50:99–107. 2013. View Article : Google Scholar : PubMed/NCBI
13	Detorakis ET and Spandidos DA: Pathogenetic mechanisms and treatment options for ophthalmic pterygium: Trends and perspectives (Review). Int J Mol Med. 23:439–447. 2009. View Article : Google Scholar : PubMed/NCBI
14	Liu L, Wu J, Geng J, Yuan Z and Huang D: Geographical prevalence and risk factors for pterygium: A systematic review and meta-analysis. BMJ Open. 3:e0037872013. View Article : Google Scholar : PubMed/NCBI
15	Julio G, Lluch S, Pujol P and Merindano D: Ocular discomfort in pterygium patients. Optom Vis Sci. 90:269–274. 2013. View Article : Google Scholar : PubMed/NCBI
16	Rachmiel R, Leiba H and Levartovsky S: Results of treatment with topical mitomycin C 0.02% following excision of primary pterygium. Br J Ophthalmol. 79:233–236. 1995. View Article : Google Scholar : PubMed/NCBI
17	Bozkir N, Yilmaz S and Maden A: Minimally invasive pterygium surgery: A new approach for prevention of recurrence. Eur J Ophthalmol. 18:27–31. 2008. View Article : Google Scholar : PubMed/NCBI
18	Ozkurt YB, Kocams O, Comez AT, Uslu B and Dogan OK: Treatment of primary pterygium. Optom Vis Sci. 86:1178–1181. 2009. View Article : Google Scholar : PubMed/NCBI
19	Varssano D, Shalev H, Lazar M and Fischer N: Pterygium excision with conjunctival autograft: True survival rate statistics. Cornea. 32:1243–1250. 2013. View Article : Google Scholar : PubMed/NCBI
20	Nelson JD: Impression cytology. Cornea. 7:71–81. 1988. View Article : Google Scholar : PubMed/NCBI
21	Singh R, Joseph A, Umapathy T, Tint NL and Dua HS: Impression cytology of the ocular surface. Br J Ophthalmol. 89:1655–1659. 2005. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Vora P, Youdim A, Thomas LS, Fukata M, Tesfay SY, Lukasek K, Michelsen KS, Wada A, Hirayama T, Arditi M and Abreu MT: Beta-defensin-2 expression is regulated by TLR signaling in intestinal epithelial cells. J Immunol. 173:5398–5405. 2004. View Article : Google Scholar : PubMed/NCBI
24	Alp S, Skrygan M, Schlottmann R, Kreuter A, Otte JM, Schmidt WE, Brockmeyer NH and Bastian A: Expression of beta-defensin 1 and 2 in nasal epithelial cells and alveolar macrophages from HIV-infected patients. Eur J Med Res. 10:1–6. 2005.PubMed/NCBI
25	Musumeci G, Carnazza ML, Leonardi R and Loreto C: Expression of β-defensin-4 in ‘an in vivo and ex vivo model’ of human osteoarthritic knee meniscus. Knee Surg Sports Traumatol Arthrosc. 20:216–222. 2012. View Article : Google Scholar : PubMed/NCBI
26	Wang XF, Cao RM, Li J, Wu J, Wu SM and Chen TX: Identification of sociodemographic and clinical factors associated with the levels of human β-defensin-1 and human β-defensin-2 in the human milk of Han Chinese. Br J Nutr. 111:867–874. 2014. View Article : Google Scholar : PubMed/NCBI
27	Suarez-Carmona M, Hubert P, Delvenne P and Herfs M: Defensins: ‘Simple’ antimicrobial peptides or broad-spectrum molecules? Cytokine Growth Factor Rev. 26:361–370. 2015. View Article : Google Scholar : PubMed/NCBI
28	Ikeda A, Sakimoto T, Shoji J and Sawa M: Expression of alpha-and beta-defensins in human ocular surface tissue. Jpn J Ophthalmol. 49:73–78. 2005. View Article : Google Scholar : PubMed/NCBI
29	Otri AM, Mohammed I, Al-Aqaba MA, Fares U, Peng C, Hopkinson A and Dua HS: Variable expression of human Beta defensins 3 and 9 at the human ocular surface in infectious keratitis. Invest Ophthalmol Vis Sci. 53:757–761. 2012. View Article : Google Scholar : PubMed/NCBI
30	Haynes RJ, McElveen JE, Dua HS, Tighe PJ and Liversidge J: Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 41:3026–3031. 2000.PubMed/NCBI
31	Huang LC, Jean D, Proske RJ, Reins RY and McDermott AM: Ocular surface expression and in vitro activity of antimicrobial peptides. Curr Eye Res. 32:595–609. 2007. View Article : Google Scholar : PubMed/NCBI
32	Jarczak J, Kościuczuk EM, Lisowski P, Strzałkowska N, Jóźwik A, Horbańczuk J, Krzyżewski J, Zwierzchowski L and Bagnicka E: Defensins: Natural component of human innate immunity. Human Immunol. 74:1069–1079. 2013. View Article : Google Scholar
33	McNAMARA NA, Van R, Tuchin OS and Fleiszig SM: Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 69:483–490. 1999. View Article : Google Scholar : PubMed/NCBI
34	McDermott AM: The role of antimicrobial peptides at the ocular surface. Ophthalmic Res. 41:60–75. 2009. View Article : Google Scholar : PubMed/NCBI
35	Mohammed I, Suleman H, Otri AM, Kulkarni BB, Chen P, Hopkinson A and Dua HS: Localization and gene expression of human beta-defensin 9 at the human ocular surface epithelium. Invest Ophthalmol Vis Sci. 51:4677–4682. 2010. View Article : Google Scholar : PubMed/NCBI
36	Garreis F, Schlorf T, Worlitzsch D, Steven P, Bräuer L, Jäger K and Paulsen FP: Roles of human beta-defensins in innate immune defense at the ocular surface: Arming and alarming corneal and conjunctival epithelial cells. Histochem Cell Biol. 134:59–73. 2010. View Article : Google Scholar : PubMed/NCBI
37	Pazgier M, Hoover DM, Yang D, Lu W and Lubkowski J: Human beta-defensins. Cell Mol Life Sci. 63:1294–1313. 2006. View Article : Google Scholar : PubMed/NCBI
38	Matsushita I, Hasegawa K, Nakata K, Yasuda K, Tokunaga K and Keicho N: Genetic variants of human beta-defensin-1 and chronic obstructive pulmonary disease. Biochem Biophys Res Commun. 291:17–22. 2002. View Article : Google Scholar : PubMed/NCBI
39	Levy H, Raby BA, Lake S, Tantisira KG, Kwiatkowski D, Lazarus R, Silverman EK, Richter B, Klimecki WT, Vercelli D, et al: Association of defensin beta-1 gene polymorphisms with asthma. J Allergy Clin Immunol. 115:252–258. 2005. View Article : Google Scholar : PubMed/NCBI
40	Andresen E, Günther G, Bullwinkel J, Lange C and Heine H: Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease. PLoS One. 6:e218982011. View Article : Google Scholar : PubMed/NCBI
41	Proud D, Sanders SP and Wiehler S: Human rhinovirus infection induces airway epithelial cell production of human beta-defensin 2 both in vitro and in vivo. J Immunol. 172:4637–4645. 2004. View Article : Google Scholar : PubMed/NCBI
42	Meloni M, De Servi B, Marasco D and Del Prete S: Molecular mechanism of ocular surface damage: Application to an in vitro dry eye model on human corneal epithelium. Mol Vis. 17:113–126. 2011.PubMed/NCBI
43	Abedin A, Mohammed I, Hopkinson A and Dua HS: A novel antimicrobial peptide on the ocular surface shows decreased expression in inflammation and infection. Invest Ophthalmol Vis Sci. 49:28–33. 2008. View Article : Google Scholar : PubMed/NCBI
44	Premratanachai P, Joly S, Johnson GK, McCray PB Jr, Jia HP and Guthmiller JM: Expression and regulation of novel human beta-defensins in gingival keratinocytes. Oral Microbiol Immunol. 19:111–117. 2004. View Article : Google Scholar : PubMed/NCBI
45	McDermott AM: Defensins and other antimicrobial peptides at the ocular surface. Ocul Surf. 2:229–247. 2004. View Article : Google Scholar : PubMed/NCBI
46	Machado LR and Ottolini B: An evolutionary history of defensins: A role for copy number variation in maximizing host innate and adaptive immune responses. Front Immunol. 6:1152015. View Article : Google Scholar : PubMed/NCBI
47	Bolaños-Jiménez R, Navas A, López-Lizárraga EP, de Ribot FM, Peña A, Graue-Hernández EO and Garfias Y: Ocular surface as barrier of innate immunity. Open Ophthalmol J. 9:49–55. 2015. View Article : Google Scholar : PubMed/NCBI
48	Chalkia AK, Spandidos DA and Detorakis ET: Viral involvement in the pathogenesis and clinical features of ophthalmic pterygium (Review). Int J Mol Med. 32:539–543. 2013. View Article : Google Scholar : PubMed/NCBI